Incentive Spirometer and Inspiratory Muscle Trainer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-02-06

Study Completion Date

2018-05-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients suffering from parkinsonism have respiratory function abnormalities. This study compared the effects of incentive spirometer and inspiratory muscle trainer on pulmonary functions in patients with parkinsonism.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

High-Intensity Respiratory Muscle Training in Individuals with Parkinson's Disease

NCT05608941

Parkinson Disease

COMPLETED NA

Effects of Inspiratory Muscle Training in Patients With Parkinson's Disease

NCT06017336

Parkinson Disease

RECRUITING NA

Impact of Customized Respiratory Training on Cardiopulmonary Function in Parkison's Disease

NCT05287243

Parkinson Disease

UNKNOWN NA

Effect of Inspiratory Muscle Training on Exercise Performance and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease

NCT02257463

Chronic Obstructive Pulmonary Disease

COMPLETED NA

Effects of Inspiratory Muscle Training on Breathing Pattern in Patients With Chronic Obstructive Pulmonary Disease

NCT02186340

Chronic Obstructive Pulmonary Disease Muscle Weakness Conditions

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The participants were recruited according to the inclusion and exclusion criteria. Participants were divided into two groups - incentive spirometer and inspiratory muscle trainer. These trainings were performed for 6 weeks duration. Several outcome measures related to pulmonary function tests were measured before and after the intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Inspiratory muscle trainer

Inspiratory muscle trainer group - Inspiratory muscle training was performed.

Group Type ACTIVE_COMPARATOR

Inspiratory muscle training

Intervention Type OTHER

Threshold inspiratory muscle training was performed for 6 weeks with device.

Incentive spirometer

Incentive spirometer group - Incentive spirometry was performed.

Group Type ACTIVE_COMPARATOR

Incentive Spirometry

Intervention Type OTHER

Incentive spirometry was performed for 6 weeks with device.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Inspiratory muscle training

Threshold inspiratory muscle training was performed for 6 weeks with device.

Intervention Type OTHER

Incentive Spirometry

Incentive spirometry was performed for 6 weeks with device.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed as having Parkinsonism Disease by the Neuro physician.
* Duration of Parkinson's Disease ≥ 5 years.
* Patients with the age of 65 to 80 years.
* Hoen and Yahr classification within 1 to 3.
* Both males and females were included.
* Patients who were able to comprehend the commands.
* Patients who were willing to participate.

Exclusion Criteria

* Patients having any cardiovascular and pulmonary disorders.
* History of smoking currently or in the past.
* Psychological Impairment.
* Insufficient verbal/intellectual understanding.
* Patients with unstable vital parameters.
* Those unable to perform pulmonary function tests (PFT) because of anatomical abnormalities or clinical signs of dementia.

Minimum Eligible Age

65 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No